ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,521.52
      -1.39%
      US Tech 100
      18,759.60
      -1.66%
      Dow Jones
      40,813.57
      -1.30%
      Brent Oil
      69.93
      -1.08%
      Bitcoin
      80,564.32
      -3.72%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Novartis AG (NVS)

      7. Novartis AG (NVS) Financials

      Novartis AG

      Novartis AG (NVS)

      Novartis CDR
      109.11
      0.47
      (0.43%)
      At close: March 13 4:00PM
      Delayed by 15 minutes
      109.12
      0.01
      ( 0.01% )
      After Hours: 4:46PM
      Delayed by 15 minutes

      Novartis AG Financial Summary

      The current NVS market cap is 215.52B. The company's latest EPS is USD 6.0458 and P/E is 18.03.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 20.09B11.83B13.16B12.17B14.56B
      Operating Income 2.84B3.34B4.01B3.62B3.53B
      Net Income 8.48B2.69B3.25B3.19B2.82B
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 49.9B52.88B51.83B54.11B51.72B
      Operating Income 10.83B27.03B9.19B10.02B14.51B
      Net Income 8.07B24.02B6.96B14.85B11.94B

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 99.95B94.33B97.51B103.52B102.25B
      Total Liabilities 53.2B54.58B55.6B60.08B58.12B
      Total Equity 46.75B39.76B41.9B43.44B44.13B
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 132.06B131.8B117.45B99.95B102.25B
      Total Liabilities 75.39B63.97B58.03B53.2B58.12B
      Total Equity 56.67B67.82B59.42B46.75B44.13B

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 9.84B2.27B7.14B13.43B17.62B
      Investing N/A -899M-4.11B-4.48B-7.51B
      Financing N/A -5.16B-8.36B-8.75B-11.74B
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 13.65B15.07B14.24B9.84B17.62B
      Investing -13.18B4.21B1.47B N/A -7.51B
      Financing -2.21B-16.26B-20.56B N/A -11.74B

      Stats and Ratios

      Market Cap 215.52B
      Price to Earnings Ratio 18.03
      Price to Sales Ratio 4.16
      Price to Cash Ratio 18.79
      Price to Book Ratio 4.88
      Dividend Yield -

      Share Statistics

      Shares Outstanding 1.98B
      Average Volume (1 week) 2.05M
      Average Volume (1 Month) 2.22M
      52 Week Change 9.47%
      52 Week High 120.92
      52 Week Low 92.35
      Spread (Intraday) 3 (2.7%)

      Company Info

      Company Name Novartis AG
      Address po box
      basel 4002
      Website https://www.novartis.com
      Industry pharmaceutical preparations (2834)

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads